PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /:
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Singapore :
BENTHAM Science PUBLISHER,
2020.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource |
| ISBN: | 9811482756 9789811482755 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1204607283 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 201111s2020 si o 000 0 eng d | ||
| 040 | |a YDX |b eng |e pn |c YDX |d N$T |d OCLCO |d EBLCP |d OCLCF |d UKAHL |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d SXB | ||
| 020 | |a 9811482756 |q (electronic bk.) | ||
| 020 | |a 9789811482755 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1204607283 | ||
| 050 | 4 | |a QR188.6 | |
| 082 | 7 | |a 616.99/4079 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / |c editors, Biaoru Li, Alan Larson, Shen Li. |
| 260 | |a Singapore : |b BENTHAM Science PUBLISHER, |c 2020. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion. | |
| 505 | 8 | |a 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION | |
| 505 | 8 | |a CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte | |
| 505 | 8 | |a GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION | |
| 505 | 8 | |a BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY | |
| 650 | 0 | |a Cancer |x Immunological aspects. |0 http://id.loc.gov/authorities/subjects/sh85019512 | |
| 650 | 0 | |a Cancer |x Immunotherapy. |0 http://id.loc.gov/authorities/subjects/sh87002642 | |
| 650 | 0 | |a Tumors |x Immunological aspects. |0 http://id.loc.gov/authorities/subjects/sh85138558 | |
| 650 | 6 | |a Cancer |x Immunologie. | |
| 650 | 6 | |a Cancer |x Immunothérapie. | |
| 650 | 6 | |a Tumeurs |x Immunologie. | |
| 650 | 7 | |a Cancer |x Immunological aspects |2 fast | |
| 650 | 7 | |a Cancer |x Immunotherapy |2 fast | |
| 650 | 7 | |a Tumors |x Immunological aspects |2 fast | |
| 655 | 4 | |a Electronic book. | |
| 700 | 1 | |a Li, Biaoru. | |
| 700 | 1 | |a Larson, Alan. | |
| 700 | 1 | |a Li, Shen. | |
| 758 | |i has work: |a Personalized immunotherapy for tumor diseases and beyond (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFpFByVQtxHXkFK8BycCKm |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH38209236 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL6424217 | ||
| 938 | |a EBSCOhost |b EBSC |n 2669216 | ||
| 938 | |a YBP Library Services |b YANK |n 301732159 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1204607283 |
|---|---|
| _version_ | 1816882532888608768 |
| adam_text | |
| any_adam_object | |
| author2 | Li, Biaoru Larson, Alan Li, Shen |
| author2_role | |
| author2_variant | b l bl a l al s l sl |
| author_facet | Li, Biaoru Larson, Alan Li, Shen |
| author_sort | Li, Biaoru |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QR188 |
| callnumber-raw | QR188.6 |
| callnumber-search | QR188.6 |
| callnumber-sort | QR 3188.6 |
| callnumber-subject | QR - Microbiology |
| collection | ZDB-4-EBA |
| contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion. 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY |
| ctrlnum | (OCoLC)1204607283 |
| dewey-full | 616.99/4079 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4079 |
| dewey-search | 616.99/4079 |
| dewey-sort | 3616.99 44079 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05070cam a2200553 a 4500</leader><controlfield tag="001">ZDB-4-EBA-on1204607283</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">201111s2020 si o 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">YDX</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">YDX</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">SXB</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9811482756</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811482755</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1204607283</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR188.6</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.99/4079</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /</subfield><subfield code="c">editors, Biaoru Li, Alan Larson, Shen Li.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Singapore :</subfield><subfield code="b">BENTHAM Science PUBLISHER,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Immunological aspects.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85019512</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh87002642</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tumors</subfield><subfield code="x">Immunological aspects.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85138558</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Immunologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Immunothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tumeurs</subfield><subfield code="x">Immunologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Immunological aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumors</subfield><subfield code="x">Immunological aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic book.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Biaoru.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Larson, Alan.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Shen.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Personalized immunotherapy for tumor diseases and beyond (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFpFByVQtxHXkFK8BycCKm</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH38209236</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6424217</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2669216</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">301732159</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Electronic book. |
| genre_facet | Electronic book. |
| id | ZDB-4-EBA-on1204607283 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:30:07Z |
| institution | BVB |
| isbn | 9811482756 9789811482755 |
| language | English |
| oclc_num | 1204607283 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | BENTHAM Science PUBLISHER, |
| record_format | marc |
| spelling | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li. Singapore : BENTHAM Science PUBLISHER, 2020. 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion. 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY Cancer Immunological aspects. http://id.loc.gov/authorities/subjects/sh85019512 Cancer Immunotherapy. http://id.loc.gov/authorities/subjects/sh87002642 Tumors Immunological aspects. http://id.loc.gov/authorities/subjects/sh85138558 Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects fast Cancer Immunotherapy fast Tumors Immunological aspects fast Electronic book. Li, Biaoru. Larson, Alan. Li, Shen. has work: Personalized immunotherapy for tumor diseases and beyond (Text) https://id.oclc.org/worldcat/entity/E39PCFpFByVQtxHXkFK8BycCKm https://id.oclc.org/worldcat/ontology/hasWork FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216 Volltext |
| spellingShingle | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion. 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY Cancer Immunological aspects. http://id.loc.gov/authorities/subjects/sh85019512 Cancer Immunotherapy. http://id.loc.gov/authorities/subjects/sh87002642 Tumors Immunological aspects. http://id.loc.gov/authorities/subjects/sh85138558 Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects fast Cancer Immunotherapy fast Tumors Immunological aspects fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85019512 http://id.loc.gov/authorities/subjects/sh87002642 http://id.loc.gov/authorities/subjects/sh85138558 |
| title | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / |
| title_auth | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / |
| title_exact_search | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / |
| title_full | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li. |
| title_fullStr | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li. |
| title_full_unstemmed | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / editors, Biaoru Li, Alan Larson, Shen Li. |
| title_short | PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND / |
| title_sort | personalized immunotherapy for tumor diseases and beyond |
| topic | Cancer Immunological aspects. http://id.loc.gov/authorities/subjects/sh85019512 Cancer Immunotherapy. http://id.loc.gov/authorities/subjects/sh87002642 Tumors Immunological aspects. http://id.loc.gov/authorities/subjects/sh85138558 Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects fast Cancer Immunotherapy fast Tumors Immunological aspects fast |
| topic_facet | Cancer Immunological aspects. Cancer Immunotherapy. Tumors Immunological aspects. Cancer Immunologie. Cancer Immunothérapie. Tumeurs Immunologie. Cancer Immunological aspects Cancer Immunotherapy Tumors Immunological aspects Electronic book. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216 |
| work_keys_str_mv | AT libiaoru personalizedimmunotherapyfortumordiseasesandbeyond AT larsonalan personalizedimmunotherapyfortumordiseasesandbeyond AT lishen personalizedimmunotherapyfortumordiseasesandbeyond |